For: | Xi N, Song X, Wang XY, Qin SF, He GN, Sun LL, Chen XM. 2+0 CYP21A2 deletion carrier — a limitation of the genetic testing and counseling: A case report. World J Clin Cases 2021; 9(23): 6789-6797 [PMID: 34447826 DOI: 10.12998/wjcc.v9.i23.6789] |
---|---|
URL: | https://www.wjgnet.com/2307-8960/full/v9/i23/6789.htm |
Number | Citing Articles |
1 |
Paola Concolino. Challenging Molecular Diagnosis of Congenital Adrenal Hyperplasia (CAH) Due to 21-Hydroxylase Deficiency: Case Series and Novel Variants of CYP21A2 Gene. Current Issues in Molecular Biology 2024; 46(5): 4832 doi: 10.3390/cimb46050291
|
2 |
Shanshan Gao, Dongping Wu, Shuai Liu, Yanlong Shen, Zhehao Zhao, Yanhua Wang, Xiangdong Kong. Detection of male 2+0 and 1+0 carriers for spinal muscular atrophy by digital PCR. Clinical Genetics 2023; 104(1): 90 doi: 10.1111/cge.14342
|
3 |
Shuyuan Li, Xu Han, Liang Zhang, Yan Xu, Chunxin Chang, Li Gao, Jiahan Zhan, Renyi Hua, Aiping Mao, Yanlin Wang. An Effective and Universal Long-Read Sequencing-Based Approach for SMN1 2 + 0 Carrier Screening through Family Trio Analysis. Clinical Chemistry 2023; 69(11): 1295 doi: 10.1093/clinchem/hvad152
|